Junshi Biosciences Unveils
ASCO 2023: Toripalimab Combination Therapy – A Breakthrough for TNBC
SG Tylor
ABSTRACT NUMBER – LBA1013 Combining taxanes-based chemotherapy with checkpoint blockade yields diverse outcomes in the first-line metastatic triple-negative breast cancer ...
